Fecal calprotectin (FC) in newborns: is it a predictive marker of gastrointestinal and/or allergic disease?

References

• Baldassarre, M.E., Altomare, M.A., Fanelli, M., Carbone, D., Di Bitonto, G., Mautone, A., Laforgia, N. Does calprotectin represent a regulatory factor in host defense or a drug target in inflammatory disease? Endocr. Metab. Immune Disord. Drug Targets 2007, 7, 1–5.
   PubMedGoogle Scholar
• Fagerberg, U.L., Lööf, L., Merzoug, R.D., Hansson, L.O., Finkel, Y. Fecal calprotectin levels in healthy children studied with an improved assay. J. Pediatr. Gastroenterol. Nutr. 2003, 37, 468–472.
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services Food and Drug Administration 21 CFR Part 866 Medical Devices, Immunology and Microbiology Devices, Classification of Fecal Calprotectin Immunological Test Systems. FEDERAL REGISTER. 2006, 71.
   Google Scholar
• Miele, E., Simeone, D., Marino, A., Greco, L., Auricchio, R., Novek, S.J., Staiano, A. Functional gastrointestinal disorders in children: an Italian prospective survey. Pediatrics 2004, 114, 73–78.
   PubMedGoogle Scholar
• Drossman, D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006, 130, 1377–1390.
   PubMed Web of Science ®Google Scholar
• Hyman, P.E., Milla, P.J., Benninga, M.A., Davidson, G.P., Fleisher, D.F., Taminiau, J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 2006, 130, 1519–1526.
   PubMed Web of Science ®Google Scholar
• Tibble, J.A., Sigthorsson, G., Foster, R., Forgacs, I., Bjarnason, I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002, 123, 450–460.
   PubMed Web of Science ®Google Scholar
• Campeotto F, Butel MJ, Kalach N, Derrieux S, Aubert-Jacquin C, Barbot L, Francoual C, Dupont C, Kapel N. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed. 2004, 89, 353–355.
   PubMed Web of Science ®Google Scholar
• Josefsson, S., Bunn, S.K., Domellöf, M. Fecal calprotectin in very low birth weight infants. J. Pediatr. Gastroenterol. Nutr. 2007, 44, 407–413.
   PubMed Web of Science ®Google Scholar
• Yang, Q., Smith, P.B., Goldberg, R.N., Cotten, C.M. Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology 2008, 94, 267–271.
   PubMed Web of Science ®Google Scholar
• Campeotto, F., Baldassarre, M., Butel, M.J., Viallon, V., Nganzali, F., Soulaines, P., Kalach, N., Lapillonne, A., Laforgia, N., Moriette, G., Dupont, C., Kapel, N. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants. J. Pediatr. Gastroenterol. Nutr. 2009, 48, 507–510.
   PubMedGoogle Scholar
• Savino, F, Castagno, E. Faecal calprotectin levels at two months of age in healthy infants and in infants with atopic and gastrointestinal disorders. Pediatric Research. 2004, 56, 503.
   Google Scholar
• Caplan, A., Walker, L., Rasquin, A. Validation of the pediatric Rome II criteria for functional gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms. J. Pediatr. Gastroenterol. Nutr. 2005, 41, 305–316.
   PubMedGoogle Scholar
• Richter, W.O. [Food allergies are often an unrecognized cause of clinical complaints]. MMW Fortschr. Med. 2005, 147, 35–38.
   PubMedGoogle Scholar
• Mckenna, S.P., Doward, L.C., Meads, D.M., Tennant, A., Lawton, G., GRUEGER, J. Quality of life in infants and children with atopic dermatitis: addressing issues of differential item functioning across countries in multinational clinical trials. Health Qual Life Outcomes 2007, 27, 5–45.
   Google Scholar
• Kapoor, R., Menon, C., Hoffstad, O., Bilker, W., Leclerc, P., Margolis, D.J. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J. Am. Acad. Dermatol. 2008, 58, 68–73.
   PubMed Web of Science ®Google Scholar
• Metcalfe, D., Sampson, H., Simon R. Food Allergy: Adverse reactions to foods and food additives. 1997 Cambrige, MA Blackwell.
   Google Scholar
• Helm, R.M. Food allergy: in-vivo diagnostics including challenge. Current Opinion in Allergy and Clinical Immunology. 2001, 1, 255–259.
   PubMedGoogle Scholar
• Niggemann, B., Beyer, K. Diagnosis of food allergy in children: toward a standardization of food challenge. J. Pediatr. Gastroenterol. Nutr. 2007, 45, 399–404.
   PubMed Web of Science ®Google Scholar
• Ferreira, C.T., Seidman, E. Food allergy: a practical update from the gastroenterological viewpoint. J. Pediatr. (Rio. J). 2007, 83, 7–20.
   PubMedGoogle Scholar
• Cash, H.L., Hooper, L.V. Commensal bacteria shape intestinal Immune system development. ASM News 2005, 2, 77–83.
   Google Scholar
• Sahl, H.G., Pag, U., Bonness, S., Wagner, S., Antcheva, N., Tossi, A. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 2005, 77, 466–475.
   PubMed Web of Science ®Google Scholar
• Wehkamp, J., Schmid, M., Fellermann, K., Stange, E.F. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn’s disease. J. Leukoc. Biol. 2005, 77, 460–465.
   PubMed Web of Science ®Google Scholar
• Nash, S., Stafford, J., Madara, J.L. Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 1987, 80, 1104–1113.
   PubMed Web of Science ®Google Scholar
• Steinbakk M., Naess-Andresen C.-F, Lingaas E., Dale I., Brandtzaeg P., Fagerhol M. K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990, 336, 763–765.
   PubMed Web of Science ®Google Scholar
• Sohnle, P. G., Collins-Lech,C., Wiessner, J. H. Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J Infect Dis 1991, 163, 187–192.
   PubMed Web of Science ®Google Scholar